Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS

S. Kalgaonkar, R. U. Almario, D. Gurusinghe, E. M. Garamendi, W. Buchan, Kyoungmi Kim, Siddika E Karakas

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background/Objectives:Polycystic ovary syndrome (PCOS) is commonly associated with insulin resistance, dyslipidemia and increased inflammation, which all benefit from dietary intake of monounsaturated and n-3 polyunsaturated fatty acids (MUFA and n-3 PUFA). Our goal was to compare the effects of MUFA-rich almonds vs n-3/n-6 PUFA-rich walnuts on metabolic and endocrine parameters in PCOS.Subjects/Methods:Thirty-one PCOS patients randomly received either walnuts or almonds containing 31 g of total fat per day for 6 weeks. At the beginning and at the end, anthropometric parameters, fasting lipids, phospholipid-fatty acids, inflammatory markers, androgens, oral glucose tolerance tests (OGTT) and frequently sampled intravenous-GTT were obtained.Results:Weight remained stable. Within group, walnuts increased the n-3/n-6 essential PUFA in the diet and plasma phospholipids. Walnuts decreased low-density lipoprotein-cholesterol by 6% from 3.76±0.27 to 3.38±0.22 mmol/l (P=0.05) and apoprotein B by 11% from 0.72±0.04 to 0.64±0.05 g/l (P<0.03). Although almonds also reduced low-density lipoprotein-cholesterol by 10% and apoprotein B by 9%, these were not significant. Walnuts increased insulin response during OGTT by 26% (P=0.02). Both walnuts and almonds increased adiponectin (walnuts from 9.5±1.6 to 11.3±1.8 μg per 100 ml, P=0.0241; almonds from 10.1±1.5 to 12.2±1.4 μg/dl, P=0.0262). Walnuts decreased HgBA1 from 5.7±0.1 to 5.5±0.1% (P=0.0006) with significant intergroup difference from almonds (P=0.0470). Walnuts increased sex hormone-binding globulin from 38.3±4.1 to 43.1±4.3 nmol/l (P=0.0038) and almonds reduced free androgen index from 2.6±0.4 to 1.8±0.3 (P=0.0470).Conclusion:Nut intake exerted beneficial effects on plasma lipids and androgens in PCOS.

Original languageEnglish (US)
Pages (from-to)386-393
Number of pages8
JournalEuropean Journal of Clinical Nutrition
Volume65
Issue number3
DOIs
StatePublished - Mar 2011

Fingerprint

Juglans
Polycystic Ovary Syndrome
Androgens
Omega-3 Fatty Acids
Apolipoproteins B
Glucose Tolerance Test
LDL Cholesterol
Phospholipids
Lipids
Prunus dulcis
Sex Hormone-Binding Globulin
Nuts
Adiponectin
Dyslipidemias
Insulin Resistance
Fasting
Fatty Acids
Fats
Insulin
Diet

Keywords

  • almonds
  • monounsaturated fatty acids
  • PCOS
  • polyunsaturated fatty acids
  • walnuts

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS. / Kalgaonkar, S.; Almario, R. U.; Gurusinghe, D.; Garamendi, E. M.; Buchan, W.; Kim, Kyoungmi; Karakas, Siddika E.

In: European Journal of Clinical Nutrition, Vol. 65, No. 3, 03.2011, p. 386-393.

Research output: Contribution to journalArticle

Kalgaonkar, S. ; Almario, R. U. ; Gurusinghe, D. ; Garamendi, E. M. ; Buchan, W. ; Kim, Kyoungmi ; Karakas, Siddika E. / Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS. In: European Journal of Clinical Nutrition. 2011 ; Vol. 65, No. 3. pp. 386-393.
@article{facf34dd35aa4288b88f9957d4f00ed4,
title = "Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS",
abstract = "Background/Objectives:Polycystic ovary syndrome (PCOS) is commonly associated with insulin resistance, dyslipidemia and increased inflammation, which all benefit from dietary intake of monounsaturated and n-3 polyunsaturated fatty acids (MUFA and n-3 PUFA). Our goal was to compare the effects of MUFA-rich almonds vs n-3/n-6 PUFA-rich walnuts on metabolic and endocrine parameters in PCOS.Subjects/Methods:Thirty-one PCOS patients randomly received either walnuts or almonds containing 31 g of total fat per day for 6 weeks. At the beginning and at the end, anthropometric parameters, fasting lipids, phospholipid-fatty acids, inflammatory markers, androgens, oral glucose tolerance tests (OGTT) and frequently sampled intravenous-GTT were obtained.Results:Weight remained stable. Within group, walnuts increased the n-3/n-6 essential PUFA in the diet and plasma phospholipids. Walnuts decreased low-density lipoprotein-cholesterol by 6{\%} from 3.76±0.27 to 3.38±0.22 mmol/l (P=0.05) and apoprotein B by 11{\%} from 0.72±0.04 to 0.64±0.05 g/l (P<0.03). Although almonds also reduced low-density lipoprotein-cholesterol by 10{\%} and apoprotein B by 9{\%}, these were not significant. Walnuts increased insulin response during OGTT by 26{\%} (P=0.02). Both walnuts and almonds increased adiponectin (walnuts from 9.5±1.6 to 11.3±1.8 μg per 100 ml, P=0.0241; almonds from 10.1±1.5 to 12.2±1.4 μg/dl, P=0.0262). Walnuts decreased HgBA1 from 5.7±0.1 to 5.5±0.1{\%} (P=0.0006) with significant intergroup difference from almonds (P=0.0470). Walnuts increased sex hormone-binding globulin from 38.3±4.1 to 43.1±4.3 nmol/l (P=0.0038) and almonds reduced free androgen index from 2.6±0.4 to 1.8±0.3 (P=0.0470).Conclusion:Nut intake exerted beneficial effects on plasma lipids and androgens in PCOS.",
keywords = "almonds, monounsaturated fatty acids, PCOS, polyunsaturated fatty acids, walnuts",
author = "S. Kalgaonkar and Almario, {R. U.} and D. Gurusinghe and Garamendi, {E. M.} and W. Buchan and Kyoungmi Kim and Karakas, {Siddika E}",
year = "2011",
month = "3",
doi = "10.1038/ejcn.2010.266",
language = "English (US)",
volume = "65",
pages = "386--393",
journal = "European Journal of Clinical Nutrition",
issn = "0954-3007",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Differential effects of walnuts vs almonds on improving metabolic and endocrine parameters in PCOS

AU - Kalgaonkar, S.

AU - Almario, R. U.

AU - Gurusinghe, D.

AU - Garamendi, E. M.

AU - Buchan, W.

AU - Kim, Kyoungmi

AU - Karakas, Siddika E

PY - 2011/3

Y1 - 2011/3

N2 - Background/Objectives:Polycystic ovary syndrome (PCOS) is commonly associated with insulin resistance, dyslipidemia and increased inflammation, which all benefit from dietary intake of monounsaturated and n-3 polyunsaturated fatty acids (MUFA and n-3 PUFA). Our goal was to compare the effects of MUFA-rich almonds vs n-3/n-6 PUFA-rich walnuts on metabolic and endocrine parameters in PCOS.Subjects/Methods:Thirty-one PCOS patients randomly received either walnuts or almonds containing 31 g of total fat per day for 6 weeks. At the beginning and at the end, anthropometric parameters, fasting lipids, phospholipid-fatty acids, inflammatory markers, androgens, oral glucose tolerance tests (OGTT) and frequently sampled intravenous-GTT were obtained.Results:Weight remained stable. Within group, walnuts increased the n-3/n-6 essential PUFA in the diet and plasma phospholipids. Walnuts decreased low-density lipoprotein-cholesterol by 6% from 3.76±0.27 to 3.38±0.22 mmol/l (P=0.05) and apoprotein B by 11% from 0.72±0.04 to 0.64±0.05 g/l (P<0.03). Although almonds also reduced low-density lipoprotein-cholesterol by 10% and apoprotein B by 9%, these were not significant. Walnuts increased insulin response during OGTT by 26% (P=0.02). Both walnuts and almonds increased adiponectin (walnuts from 9.5±1.6 to 11.3±1.8 μg per 100 ml, P=0.0241; almonds from 10.1±1.5 to 12.2±1.4 μg/dl, P=0.0262). Walnuts decreased HgBA1 from 5.7±0.1 to 5.5±0.1% (P=0.0006) with significant intergroup difference from almonds (P=0.0470). Walnuts increased sex hormone-binding globulin from 38.3±4.1 to 43.1±4.3 nmol/l (P=0.0038) and almonds reduced free androgen index from 2.6±0.4 to 1.8±0.3 (P=0.0470).Conclusion:Nut intake exerted beneficial effects on plasma lipids and androgens in PCOS.

AB - Background/Objectives:Polycystic ovary syndrome (PCOS) is commonly associated with insulin resistance, dyslipidemia and increased inflammation, which all benefit from dietary intake of monounsaturated and n-3 polyunsaturated fatty acids (MUFA and n-3 PUFA). Our goal was to compare the effects of MUFA-rich almonds vs n-3/n-6 PUFA-rich walnuts on metabolic and endocrine parameters in PCOS.Subjects/Methods:Thirty-one PCOS patients randomly received either walnuts or almonds containing 31 g of total fat per day for 6 weeks. At the beginning and at the end, anthropometric parameters, fasting lipids, phospholipid-fatty acids, inflammatory markers, androgens, oral glucose tolerance tests (OGTT) and frequently sampled intravenous-GTT were obtained.Results:Weight remained stable. Within group, walnuts increased the n-3/n-6 essential PUFA in the diet and plasma phospholipids. Walnuts decreased low-density lipoprotein-cholesterol by 6% from 3.76±0.27 to 3.38±0.22 mmol/l (P=0.05) and apoprotein B by 11% from 0.72±0.04 to 0.64±0.05 g/l (P<0.03). Although almonds also reduced low-density lipoprotein-cholesterol by 10% and apoprotein B by 9%, these were not significant. Walnuts increased insulin response during OGTT by 26% (P=0.02). Both walnuts and almonds increased adiponectin (walnuts from 9.5±1.6 to 11.3±1.8 μg per 100 ml, P=0.0241; almonds from 10.1±1.5 to 12.2±1.4 μg/dl, P=0.0262). Walnuts decreased HgBA1 from 5.7±0.1 to 5.5±0.1% (P=0.0006) with significant intergroup difference from almonds (P=0.0470). Walnuts increased sex hormone-binding globulin from 38.3±4.1 to 43.1±4.3 nmol/l (P=0.0038) and almonds reduced free androgen index from 2.6±0.4 to 1.8±0.3 (P=0.0470).Conclusion:Nut intake exerted beneficial effects on plasma lipids and androgens in PCOS.

KW - almonds

KW - monounsaturated fatty acids

KW - PCOS

KW - polyunsaturated fatty acids

KW - walnuts

UR - http://www.scopus.com/inward/record.url?scp=79952441113&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952441113&partnerID=8YFLogxK

U2 - 10.1038/ejcn.2010.266

DO - 10.1038/ejcn.2010.266

M3 - Article

C2 - 21157477

AN - SCOPUS:79952441113

VL - 65

SP - 386

EP - 393

JO - European Journal of Clinical Nutrition

JF - European Journal of Clinical Nutrition

SN - 0954-3007

IS - 3

ER -